Vivani Medical, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Vivani Medical, Inc. on October 17, 2022. The filing serves to disclose upcoming investor communications and present materials related to the company's operations and strategy.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on event disclosure rather than financial performance data.
Material Changes
No material changes to financial position or operations are reported in this document. The filing announces a scheduled corporate event.
Guidance, Outlook, and Management Commentary
- Upcoming Event: The Company will present at the ThinkEquity Investor Conference on October 26, 2022, at 11:00 am EDT at the Mandarin Oriental in New York.
- Management Participation: Dr. Adam Mendelsohn, CEO, will present a company overview. Brigid Makes, CFO, will host one-on-one meetings with investors.
- Access: The presentation is available live via webcast and a replay will be hosted on the company website.
- Exhibits: Presentation materials (Exhibit 99.1) and a press release (Exhibit 99.2) are attached to this filing.
- Disclaimer: The Company disclaims any obligation to update the presentation materials or reflect events occurring after the date of this report.
Key Facts for Investor Verification
- Verify the date and time of the ThinkEquity Investor Conference presentation (October 26, 2022).
- Review the attached Exhibit 99.1 for the specific content of the CEO and CFO presentation materials.
- Confirm the availability of the live webcast link and replay on the company website.
- Note that the presentation materials are not deemed "filed" for purposes of Section 18 of the Exchange Act.